Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose pirfenidone safety and pharmacokinetics in chronic kidney disease G2/G3a
ChiCTR2300077297Phase 4Completed
- Sponsor
- Union Hospital
- Start
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of pirfenidone in chronic kidney disease (CKD) (2 arms), sponsored by Union Hospital. Primary endpoints: Plasma pirfenidone concentration and Urine pirfenidone concentration. Started Dec 2019; status: completed.
02
Drugs
pirfenidone
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on ChiCTR2300077297.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300077297.